TLN-4601, a novel anticancer agent, inhibits Ras signaling post Ras prenylation and before MEK activation

Published 2010 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
TLN-4601, a novel anticancer agent, inhibits Ras signaling post Ras prenylation and before MEK activation
Authors
Keywords
-
Journal
ANTI-CANCER DRUGS
Volume 21, Issue 5, Pages 543-552
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2010-03-23
DOI
10.1097/cad.0b013e328337f373

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.